1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"Multiple Sclerosis Research Program (MSRP) Exploration – Hypothesis Development Award (EHDA)" is currently closed and not accepting applications.
Multiple Sclerosis Research Program (MSRP) Exploration – Hypothesis Development Award (EHDA) is sponsored by Department of Defense (DOD) Congressionally Directed Medical Research Programs (CDMRP). The FY26 MSRP EHDA supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in MS research.
Studies are expected to lay the groundwork for future scientific investigation and must address at least one of the FY26 MSRP EHDA focus areas. Proposed research projects should include a well-formulated, testable hypothesis based on strong scientific rationale and study design.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Independent investigators. The New Investigator option supports applicants early in their faculty appointments who are within five years from the start of their non-mentored position and have not received more than $300,000 in total direct costs for previous or concurrent MS research as a PI of non-mentored, peer-reviewed grants. Confirm the full requirements in the official notice before applying.
The current listing shows approximately $250,000 total costs per award (anticipated funding for approximately eight awards). Maximum project period is 2 years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was August 14, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Multiple Sclerosis Research Program (MSRP) Exploration – Hypothesis Development Award (EHDA) is funded by Department of Defense (DOD) Congressionally Directed Medical Research Programs (CDMRP). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Rare Cancers Research Program (RCRP) Concept Award is sponsored by Department of Defense (DOD) Congressionally Directed Medical Research Programs (CDMRP). The FY26 RCRP Concept Award supports highly innovative, untested, potentially groundbreaking novel concepts in rare cancers. This award mechanism supports high-risk studies that have the potential to reveal entirely new avenues for investigation in rare cancers.
Pancreatic Cancer Research Program, Idea Development Award is sponsored by Department of Defense (DOD) Congressionally Directed Medical Research Programs (CDMRP). This award mechanism supports the development of innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements to accelerate progress in improving outcomes for individuals with pancreatic cancer.
CDMRP's FY26 portfolio funds 34 programs, and October 2026 is dense with full-application deadlines: PRCRP October 5, PCRP October 7, MRP October 14. Every one of them is gated behind a pre-application that closed months earlier. Here is what that two-step structure actually costs applicants, and how to be inside the gate for FY27.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read articleThe memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read article